| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 106, 1599-1606, Copyright © 1980 by Endocrine Society
ARTICLES |
MH Abel and DT Baird
Endometrium collected from 18 normal women at various stages of the menstrual cycle was maintained in organ culture for periods of 6 days. Both prostaglandin F2 alpha (PGF2 alpha) and PGE were detected in medium from late proliferative (days 10-14; n = 13) and late secretory (days 20-26; n = 5) endometria cultured in the absence of exogenous steroids. During the first 48 h in culture, the output of PGF2 alpha by secretory endometrium was significantly greater than that of proliferative tissue. The addition of 17 beta-estradiol to the culture medium at doses ranging from 1.0-100.0 ng/ml induced a significant increase in the output of PGF2 alpha by secretory but not proliferative endometria. The addition of progesterone at doses ranging from 5.0- 500.0 ng/ml significantly reduced the output of PGF2 alpha and PGE by both proliferative and secretory endometria and prevented the 17 beta- estradiol-stimulated increase in PGF2 alpha output by secretory tissue.
This article has been cited by other articles:
![]() |
F. Modugno, R. B. Ness, C. Chen, and N. S. Weiss Inflammation and Endometrial Cancer: A Hypothesis Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2840 - 2847. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Li, J.C. Felix, J. Hao, P. Minoo, and J.K. Jain Menstrual-like breakdown and apoptosis in human endometrial explants Hum. Reprod., June 1, 2005; 20(6): 1709 - 1719. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Sales, S. A. Milne, A. R. W. Williams, R. A. Anderson, and H. N. Jabbour Expression, Localization, and Signaling of Prostaglandin F2{alpha} Receptor in Human Endometrial Adenocarcinoma: Regulation of Proliferation by Activation of the Epidermal Growth Factor Receptor and Mitogen-Activated Protein Kinase Signaling Pathways J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 986 - 993. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Milne and H. N. Jabbour Prostaglandin (PG) F2{alpha} Receptor Expression and Signaling in Human Endometrium: Role of PGF2{alpha} in Epithelial Cell Proliferation J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1825 - 1832. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Hapangama, H. O. D. Critchley, T. A. Henderson, and D. T. Baird Mifepristone-Induced Vaginal Bleeding Is Associated with Increased Immunostaining for Cyclooxygenase-2 and Decrease in Prostaglandin Dehydrogenase in Luteal Phase Endometrium J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5229 - 5234. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sugino, A. Karube-Harada, S. Kashida, S. Takiguchi, and H. Kato Reactive oxygen species stimulate prostaglandin F2{alpha} production in human endometrial stromal cells in vitro Hum. Reprod., September 1, 2001; 16(9): 1797 - 1801. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. McCracken, E. E. Custer, and J. C. Lamsa Luteolysis: A Neuroendocrine-Mediated Event Physiol Rev, April 1, 1999; 79(2): 263 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. O. D. Critchley, R. L. Jones, R. G. Lea, T. A. Drudy, R. W. Kelly, A. R. W. Williams, and D. T. Baird Role of Inflammatory Mediators in Human Endometrium during Progesterone Withdrawal and Early Pregnancy J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 240 - 248. [Abstract] [Full Text] |
||||
![]() |
W. X. Wu, X. H. Ma, Q. Zhang, L. Buchwalder, and P. W. Nathanielsz Regulation of Prostaglandin Endoperoxide H Synthase 1 and 2 by Estradiol and Progesterone in Nonpregnant Ovine Myometrium and Endometrium in Vivo Endocrinology, September 1, 1997; 138(9): 4005 - 4012. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Graham and C. L. Clarke Physiological Action of Progesterone in Target Tissues Endocr. Rev., August 1, 1997; 18(4): 502 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Lockwood and F. Schatz A Biological Model for the Regulation of Peri-Implantational Hemostasis and Menstruation Reproductive Sciences, July 1, 1996; 3(4): 159 - 165. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |